Abstract:Cholinergic degeneration is significant in Lewy body disease, including Parkinson's disease, dementia with Lewy bodies, and isolated REM sleep behavior disorder. Extensive research has demonstrated cholinergic alterations in the central nervous system of these disorders. More recently, studies have revealed cholinergic denervation in organs that receive parasympathetic denervation. This enables a comprehensive review of cholinergic changes in Lewy body disease, encompassing both central and peripheral regions, various disease stages, and diagnostic categories. Across studies, brain regions affected in Lewy body dementia show equal or greater levels of cholinergic impairment compared to the brain regions affected in Lewy body disease without dementia. This observation suggests a continuum of cholinergic alterations between these disorders. Patients without dementia exhibit relative sparing of limbic regions, whereas occipital and superior temporal regions appear to be affected to a similar extent in patients with and without dementia. This implies that posterior cholinergic cell groups in the basal forebrain are affected in the early stages of Lewy body disorders, while more anterior regions are typically affected later in the disease progression. The topographical changes observed in patients affected by comorbid Alzheimer pathology may reflect a combination of changes seen in pure forms of Lewy body disease and those seen in Alzheimer's disease. This suggests that Alzheimer co-pathology is important to understand cholinergic degeneration in Lewy body disease. Thalamic cholinergic innervation is more affected in Lewy body patients with dementia compared to those without dementia, and this may contribute to the distinct clinical presentations observed in these groups. In patients with Alzheimer's disease, the thalamus is variably affected, suggesting a different sequential involvement of cholinergic cell groups in Alzheimer's disease compared to Lewy body disease. Patients with isolated REM sleep behavior disorder demonstrate cholinergic denervation in abdominal organs that receive parasympathetic innervation from the dorsal motor nucleus of the vagus, similar to patients who experienced this sleep disorder in their prodrome. This implies that REM sleep behavior disorder is important for understanding peripheral cholinergic changes in both prodromal and manifest phases of Lewy body disease. In conclusion, cholinergic changes in Lewy body disease carry implications for understanding phenotypes and the influence of Alzheimer co-pathology, delineating subtypes and pathological spreading routes, and for developing tailored treatments targeting the cholinergic system.

[Psychiatric symptoms of Lewy body dementia]

Clinical features of Lewy body dementia: insights into diagnosis and pathophysiology

Lewy body dementia: the impact on patients and caregivers

Behavioral disorders in dementia with Lewy bodies: old and new knowledge

Clinical analysis of dementia with lewy body

Prodromal Dementia With Lewy Bodies: Evolution of Symptoms and Predictors of Dementia Onset

Dementia with Lewy bodies: Challenges in the diagnosis and management

Clinical Characteristics of Lewy Body Dementia in Chinese Memory Clinics

Faster cognitive decline in dementia due to Alzheimer disease with clinically undiagnosed Lewy body disease

DEMENCIA WITH LEWY BODIES IN EXPERT ASSESSMENT OF SOCIAL SECURITY

Non-Pharmacological Treatments in Lewy Body Disease: A Systematic Review

Differentiating Prodromal Dementia with Lewy Bodies from Prodromal Alzheimer's Disease: A Pragmatic Review for Clinicians

Clinical features of dementia with lewy bodies in 35 Chinese patients

Clinical and video-polysomnographic analysis of rapid eye movement sleep behavior disorder and other sleep disturbances in dementia with Lewy bodies

Prodromal dementia with Lewy bodies in REM sleep behavior disorder: A multicenter study

FC20: Prevalence, Incidence, and Clinical Features of Lewy Body Dementia in the South Eastern of Spain

Frequency and clinical features of Lewy body dementia in Italian memory clinics

Lewy Body Disease: Clinical and Pathological "Overlap Syndrome" Between Synucleinopathies (Parkinson Disease) and Tauopathies (Alzheimer Disease)

A Population‐Based Approach to the Argument on Brain‐First and Body‐First Pathogenesis of Lewy Body Disease

SENSE-Cog Lewy: Investigating the Impact of Sensory Loss on the Diagnosis, Clinical Features and Prognosis of Lewy Body Dementia

Cholinergic changes in Lewy body disease: implications for presentation, progression and subtypes